Warfarin more harmful to bone health than DOACs
The free daily newsletter covering the top cardiovascular headlines
Related Articles
FDA clears AI platform for planning ahead of TAVR, other heart procedures
The cloud-based platform identifies and measures cardiac structures in CT scans.
Cardiac PET on the rise among U.S. cardiologists
SPECT is still the most common modality used to evaluate CAD patients, but cardiac PET is gaining more and more momentum.
TRILUMINATE update: TEER with Abbott’s TriClip device still safe, effective after 3 years
Treatment with TriClip has been consistently associated with minimal adverse events and significant improvements in quality of life. This latest update represents data from nearly…
Implantable Barostim device improves long-term heart failure symptoms
The FDA-approved device helps regulate the heart, kidneys and vascular system by targeting sensors in a patient’s carotid artery.
New SCCT president takes office, lists priorities
Maros Ferencik, MD, noted that the Society of Cardiovascular Computed Tomography represents specialists from many different specialties, including cardiology, radiology and beyond.
TRILUMINATE update: TEER with Abbott’s TriClip device still safe, effective after 3 years
Treatment with TriClip has been consistently associated with minimal adverse events and significant improvements in quality of life. This latest update represents data from nearly…
A new vision for the JACC: Interview with JACC Editor-in-Chief Harlan Krumholz
Harlan Krumholz, MD, editor-in-chief of the Journal of the American College of Cardiology (JACC), explains changes in how the journals will be reviewing articles and…
Estrogen-based hormone therapy may be good for heart health
Physicians and patients alike have often wondered if these therapies are bad for the heart. It turns out, according to this new analysis, that they…
Remote monitoring, AI to play key roles in the future of cardiology
Serious changes could be coming to a cardiology practice near you.
Abiomed, Biosense Webster, Cerenovus now all known as Johnson & Johnson MedTech
These companies were already part of the Johnson & Johnson family, but they had still retained their previous brand names. Now, each one is officially…